Physical Exercise for Patients With Head and Neck Cancer - Trial NCT05988060
Access comprehensive clinical trial information for NCT05988060 through Pure Global AI's free database. This phase not specified trial is sponsored by Institute Verbeeten and is currently Recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 112 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institute Verbeeten
Timeline & Enrollment
N/A
Nov 09, 2022
Nov 09, 2026
Primary Outcome
physical performance
Summary
The goal of this trial within cohorts study is to determine and compare physical performance,
 muscle strength, fatigue, quality of life, body composition, nutritional status, physical
 activity, treatment tolerability of radiotherapy (RT), chemoradiation (CRT) or bioradiation
 (BRT), and healthcare related costs in patients with head and neck cancer (HNC) with and
 without a 10 week physical exercise intervention (PEI) during RT, CRT or BRT ((C/B)RT).
 
 Patients who were randomized in the PEI group and accepted the invitation to undergo the
 experimental intervention receive a PEI twice a week for 10 weeks. The PEI will be executed 6
 to 7 weeks during and 3 to 4 weeks after (C/B)RT.
 
 Researchers will compare patients who undergo the PEI with patients who did not undergo the
 PEI to see if there is difference in physical performance, muscle strength, fatigue, Quality
 of Life, body composition, nutritional status, physical activity, treatment tolerability of
 (C/B)RT , and healthcare related costs in patients with Head and Neck Cancer (HNC) with and
 without a 10 week Physical Exercise Intervention (PEI) during (C/B)RT).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05988060
Non-Device Trial